Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection

Nucleic Acids Research

Volumn 42, Issue 19, 2014, Pages 12070-12081

  Bielli, Pamela ^a,b   Bordi, Matteo ^a,b,c   Di Biasio, Valentina ^a,b,d   Sette, Claudio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPYRIMIDINE TRACT BINDING PROTEIN; PROTEIN BCL X; PROTEIN PTBP1; RNA; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; NUCLEAR PROTEIN; PTBP1 PROTEIN, HUMAN; RNA BINDING PROTEIN; RNA SPLICING; SERINE-ARGININE-RICH SPLICING PROTEINS;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; BCL X GENE; BINDING SITE; CONTROLLED STUDY; GENE; GENE REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; USP5 GENE; ANTAGONISTS AND INHIBITORS; EXON; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; RNA SPLICING; TUMOR CELL LINE;

ALTERNATIVE SPLICING; BCL-X PROTEIN; CELL LINE, TUMOR; EXONS; HEK293 CELLS; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; NUCLEAR PROTEINS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RNA SPLICE SITES; RNA-BINDING PROTEINS;

EID: 84925283590     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku922     Document Type: Article

References (53)

1. Braunschweig, U., Gueroussov, S., Plocik, A.M., Graveley, B.R. and Blencowe, B.J. (2013) Dynamic integration of splicing within gene regulatory pathways. Cell, 152, 1252-1269.
2. Matera, A.G. and Wang, Z. (2014) A day in the life of spliceosome. Nat. Rev. Mol. Cell Biol., 15, 108-121.
3. Black, D.L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem., 72, 291-336.
4. Wahl, M.C., Will, C.L. and Lührmann, R. (2009) The spliceosome: Design principles of a dynamic RNP machine. Cell, 136, 701-718.
5. Chen, M. and Manley, J.L. (2009) Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol., 10, 741-754.
6. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
7. Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S.F., Schroth, G.P. and Burge, C.B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
8. Kalsotra, A. and Cooper, T.A. (2011) Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet., 12, 715-729.
9. Luco, R.F., Allo, M., Schor, I.E., Kornblihtt, A.R. and Misteli, T. (2011) Epigenetics in alternative pre-mRNA splicing. Cell, 144, 16-26.
10. Jacobs, E., Mills, J.D. and Janitz, M. (2012) The role of RNA structure in posttranscriptional regulation of gene expression. J. Genet. Genomics, 39, 535-543.
11. Singh, R., Valcárcel, J. and Green, M.R. (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science, 268, 1173-1176.
12. Zheng, X., Cho, S., Moon, H., Loh, T.J., Oh, H.K., Green, M.R. and Shen, H. (2014) Polypyrimidine tract binding protein inhibits IgM pre-mRNA splicing by diverting U2 snRNA base-pairing away from the branch point. RNA, 20, 440-446.
13. Sharma, S., Maris, C., Allain, F.H. and Black, D.L. (2011) U1 snRNA directly interacts with polypyrimidine tract-binding protein during splicing repression. Mol. Cell, 41, 579-588.
14. Ule, J., Stefani, G., Mele, A., Ruggiu, M., Wang, X., Taneri, B., Gaasterland, T., Blencowe, B.J. and Darnell, R.B. (2006) An RNA map predicting Nova-dependent splicing regulation. Nature, 444, 580-586.
15. Yeo, G.W., Coufal, N.G., Liang, T.Y., Peng, G.E., Fu, X.D. and Gage, F.H. (2009) An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol., 16, 130-137.
16. Xue, Y., Zhou, Y., Wu, T., Zhu, T., Ji, X., Kwon, Y.S., Zhang, C., Yeo, G., Black, D.L., Sun, H. et al. (2009) Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell, 36, 996-1006.
17. Llorian, M., Schwartz, S., Clark, T.A., Hollander, D., Tan, L.Y., Spellman, R., Gordon, A., Schweitzer, A.C., de la Grange, P., Ast, G. et al. (2010) Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol., 17, 1114-1123.
18. Cooper, TA., Wan, L. and Dreyfuss, G. (2009) RNA and desease. Cell, 136, 777-793.
19. Schwerk, C. and Schulze-Osthoff, K. (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell, 19, 1-13.
20. Thomas, M.P. and Lieberman, J. (2013) Live or let die: Posttranscriptional gene regulation in cell stress and cell death. Immunol. Rev., 253, 237-252.
21. Boise, L.H., Gonzáles-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nuñez, G. and Thompson, C.B. (1993) bcl-x, a bcl-2-related gene that function as a dominant regulator of apoptotic cell death. Cell, 74, 507-608.
22. Moore, M.J., Wang, Q., Kennedy, C.J. and Silver, P.A. (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell, 142, 625-636.
23. Olopade, O.I., Adeyanju, M.O., Safa, A.R., Hagos, F., Mick, R., Thompson, C.B. and Recant, W.M. (1997) Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am., 3, 230-237.
24. Takehara, T., Liu, X., Fujimoto, J., Friedman, S.L. and Takahashi, H. (2001) Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology, 34, 55-61.
25. Mercatante, D.R., Mohler, J.L. and Kole, R. (2002) Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J. Biol. Chem., 277, 49374-49782.
26. Garneau, D., Revil, T., Fisette, J.F. and Chabot, B. (2005) Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem., 280, 22641-22650.
27. Paronetto, M.P., Achsel, T., Massiello, A., Chalfant, C.E. and Sette, C. (2007) The RNA-binding protein SAM68 modulates the alternative splicing of Bcl-x. J. Cell Biol., 176, 929-939.
28. Cloutier, P., Toutant, J., Shkreta, L., Goekjian, S., Revil, T. and Chabot, B. (2008) Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x. J. Biol. Chem., 283, 21315-21324.
29. Revil, T., Pelletier, J., Toutant, J., Cloutier, A. and Chabot, B. (2009) Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform. J. Biol. Chem., 284, 21458-21467.
30. Pedrotti, S., Busà, R., Compagnucci, C. and Sette, C. (2012) The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator. Nucleic Acids Res., 40, 1021-1032.
31. Naro, C., Barbagallo, F., Chieffi, P., Bourgeois, C.F., Paronetto, M.P. and Sette, C. (2014) The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival. Nucleic Acids Res., 42, 3218-3227.
32. Montes, M., Cloutier, A., Sánchez-Hernández, N., Michelle, L., Lemieux, B., Blanchette, M., Hernández-Munain, C., Chabot, B. and Suñé, C. (2011) TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription. Mol. Cell. Biol., 32, 751-762.
33. Bielli, P., Busà, R., Di Stasi, S.M., Munoz, M.J., Botti, F., Kornblihtt, A.R. and Sette, C. (2014) The transcription factor FBI-1 modulates SAM68-mediated BCL-X alternative splicing and apoptosis. EMBO Rep., 15, 419-427.
34. Michelle, L., Cloutier, A., Toutant, J., Shkreta, L., Thibault, P., Durand, M., Garneau, D., Gendron, D., Lapointe, E., Couture, S. et al. (2012) Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators. Mol. Cell. Biol., 32, 954-967.
35. Bauman, J.A., Li, S.D., Yang, A., Huang, L. and Kole, R. (2010) Anti-tumor activity of splice-switching oligonucleotides. Nucleic Acids Res., 38, 8348-8356.
36. Kole, R., Krainer, A.R. and Altman, S. (2012) RNA therapeutics: Beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov., 11, 125-140.
37. Massiello, A., Salas, A., Pinkerman, R.L., Roddy, P., Roesser, J.R. and Chalfant, C.E. (2004) Identification of two RNA cis-elements that function to regulate the 5' SS selection of Bcl-x premRNA in response to ceramide. J. Biol. Chem., 279, 15799-15804.
38. Barik, S. (1996) Site-directed mutagenesis in vitro by megaprimer PCR. Methods Mol. Biol., 57, 203-215.
39. Pedrotti, S., Bielli, P., Paronetto, M.P., Ciccosanti, F., Fimia, G.M., Stamm, S., Manley, J.L. and Sette, C. (2010) The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy. EMBO J., 29, 1235-1247.
40. Wang, Z., Tollervey, J., Briese, M., Turner, D. and Ule, J. (2009) CLIP: Construction of cDNA libraries for high-throughput sequencing from RNAs cross-linked to proteins in vivo. Methods, 48, 287-293.
41. Revil, T., Toutant, J., Shkreta, L., Garneau, D., Cloutier, P. and Chabot, B. (2007) Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol., 27, 8431-8441.
42. Chen, Z.Y., Cai, L., Zhu, J., Chen, M., Chen, J., Li, Z.H., Liu, X.D., Wang, S.G., Bie, P., Jiang, P. et al. (2011) Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis, 32, 1419-1426.
43. Jin, W., McCutcheon, I.E., Fuller, G.N., Huang, E.S. and Cote, G.J. (2000) Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res., 60, 1221-1224.
44. Clower, C.V., Chatterjee, D., Wang, Z., Cantley, L.C., Vander-Heiden, M.G. and Krainer, A.R. (2010) The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl. Acad. Sci. U.S.A., 107, 1894-1899.
45. David, C.J., Chen, M., Assanah, M., Canoll, P. and Manley, J.L. (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature, 463, 364-368.
46. Ferrarese, R., Harsh, G.R. IV, Yadav, A.K., Bug, E., Maticzka, D., Reichardt, W., Dombrowski, S.M., Miller, T.E., Masilamani, A.P., Dai, F. et al. (2014) Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. J. Clin. Invest., 124, 2861-2876.
47. Kafasla, P., Mickleburgh, I., Llorian, M., Coelho, M., Gooding, C., Cherny, D., Joshi, A., Kotik-Kogan, O., Curry, S., Eperon, I.C. et al. (2012) Defining the roles and interactions of PTB. Biochem. Soc. Trans., 40, 815-820.
48. Erkelenz, S., Mueller, W.F., Evans, M.S., Busch, A., Schöneweis, K., Hertel, K.J. and Schaal, H. (2013) Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA, 19, 96-102.
49. Izaguirre, D.I., Zhu, W., Hai, T., Cheung, H.C., Krahe, R. and Cote, G.J. (2012) PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Mol. Carcinog., 51, 895-906.
50. Rigo, F., Hua, Y., Krainer, A.R. and Bennett, C.F. (2012) Antisense-based therapy for the treatment of spinal muscular atrophy. J. Cell Biol., 199, 21-25.
51. Koo, T. and Wood, M.J. (2013) Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy. Hum. Gene Ther., 24, 479-488.
52. Das, S. and Krainer, A.R. (2014) Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res., 12, 1195-1204.
53. Kohtz, J.D., Jamison, S.F., Will, C.L., Zuo, P., Lührmann, R., Garcia-Blanco, M.A. and Manley, J.L. (1994) Protein-protein interactions and 5-splice-site recognition in mammalian mRNA precursors. Nature, 368, 119-124.